1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Severe Pneumonia: new trials by email Literature Review of Severe Pneumonia trials Research Report on Severe Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reparixin in COVID-19 Pneumonia - Efficacy and Safety Reparixin, Standard of care - Severe Pneumonia | Phase 2 / Phase 3 | Terminated | Dompé Farmaceutici S.p.A | 56 | 2020-05-05 | 2024-01-08 |
Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Standard of Care (1) · reparixin (1)
Brazil (1) · Italy (1)
Alberto Zangrillo, MD PhD (1) · Lorenzo Piemonti, MD PhD (1)